Opus Genetics (IRD) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.98% |
| Dec 31, 2025 | -30.76% |
| Sep 30, 2025 | -20.50% |
| Jun 30, 2025 | 6.18% |
| Mar 31, 2025 | -33.53% |
| Dec 31, 2024 | -32.87% |
| Sep 30, 2024 | 18.59% |
| Jun 30, 2024 | 21.68% |
| Mar 31, 2024 | 67.41% |
| Dec 31, 2023 | 78.69% |
| Sep 30, 2023 | 94.37% |
| Jun 30, 2023 | 84.65% |
| Mar 31, 2023 | 90.15% |
| Dec 31, 2022 | 100.96% |
| Sep 30, 2022 | 0.34% |
| Jun 30, 2022 | 2.32% |
| Mar 31, 2022 | 2.71% |
| Dec 31, 2021 | 147.06% |
| Sep 30, 2021 | 47.48% |
| Jun 30, 2021 | 25.45% |
| Mar 31, 2021 | -13.12% |
| Dec 31, 2020 | -41.00% |
| Sep 30, 2020 | -37.90% |
| Jun 30, 2020 | -36.66% |
| Mar 31, 2020 | -111.72% |
| Dec 31, 2019 | -34.68% |
| Sep 30, 2019 | -11.98% |
| Jun 30, 2019 | -4.85% |
| Mar 31, 2019 | -2.52% |
| Dec 31, 2018 | -27.86% |
| Sep 30, 2018 | -28.72% |
| Jun 30, 2018 | -18.92% |
| Mar 31, 2018 | -13.81% |
| Dec 31, 2017 | -14.23% |
| Sep 30, 2017 | -19.14% |
| Jun 30, 2017 | -19.35% |
| Mar 31, 2017 | -65.72% |
| Dec 31, 2016 | 10.55% |
| Sep 30, 2016 | 20.51% |
| Jun 30, 2016 | 42.18% |
| Mar 31, 2016 | 27.13% |
| Dec 31, 2015 | 25.34% |
| Sep 30, 2015 | 55.19% |
| Jun 30, 2015 | 40.87% |
| Mar 31, 2015 | 39.25% |
| Dec 31, 2014 | 35.41% |
| Sep 30, 2014 | 41.14% |
| Jun 30, 2014 | 38.22% |
| Dec 31, 2013 | 6.69% |